Darren is Vice President of the New Ventures division of Eli Lilly and Company, which includes Lilly Ventures and Lilly Asian Ventures, the first venture capital group of its kind in the pharmaceutical industry. Prior to assuming his current role, Darren was the founding Chief Executive Officer of InnoCentive, Inc., the first open-innovation business in the physical sciences, which he spun out of Lilly. Among other positions Darren has held at Lilly, he was the U.S. attorney for Prozac®.
Darren has also served as Senior Vice President of RealMed, a venture-backed company based in Indianapolis, which created the first real-time health claims adjudication system. Earlier in Darren's career, he practiced law with a large private law firm in New York and negotiated complex technology transactions for General Electric Company.
Darren's education includes a J.D. degree from Syracuse University College of Law. He also holds a bachelor's from Syracuse University and a masters of public administration degree from the Maxwell School of Syracuse, where he is a member of the Board of Advisors. Darren is also a member of the Board of Directors for Lilly Ventures and Lilly Asian Ventures portfolio companies including Citic Pharmaceuticals, Novast Holdings, InnoCentive and GlobeImmune, and is chairman of the advisory board for the Indiana Future Fund and the INext Fund.